# Epigenomic Analysis for Biomarker Discovery in Colorectal Cancer

Welcome to the **Epigenomic-analysis-for-biomarker-discovery--Colorectal-cancer** project repository.

---

## Project Overview

Colorectal cancer (CRC) remains a major global health challenge due to its **high incidence and mortality rates**. Despite significant progress in cancer genomics, growing evidence indicates that **epigenetic modifications**—in addition to genetic mutations—play a critical role in **tumor initiation, progression, and therapeutic response**.

Epigenetic mechanisms, including **DNA methylation**, **histone modifications**, and **RNA-based regulatory processes**, influence gene expression without altering the DNA sequence. Dysregulation of these processes contributes significantly to colorectal tumorigenesis and disease heterogeneity.

---

## Project Aim

This project aims to perform a **systematic epigenomic analysis of colorectal cancer** using an integrated, RNA-focused approach. The primary goals are to:

- Identify **disease-associated genes**
- Characterize **regulatory networks and signaling pathways**
- Analyze **gene expression signatures** relevant to colorectal cancer
- Discover **novel epigenomic and transcriptomic biomarkers**

---
## 🎯 Project Goal

The primary goal of this project is to identify clinically relevant genetic biomarkers associated with colorectal cancer (CRC) by developing and applying a reproducible, GATK best-practices–based next-generation sequencing (NGS) analysis pipeline, with a focused emphasis on the KRAS gene located on chromosome 12.

Using publicly available whole-exome sequencing (WES) data, this project aims to:

- Process raw paired-end sequencing reads through quality control, alignment, and post-alignment processing
- Perform duplicate marking and base quality score recalibration (BQSR) to improve the reliability of detected variants
- Conduct chromosome-specific variant discovery (chr12) using GATK HaplotypeCaller
- Identify high-confidence single nucleotide variants (SNVs) and small insertions/deletions (INDELs) with potential biomarker relevance
- Generate analysis-ready variant datasets suitable for functional annotation and clinical interpretation
- Demonstrate a computationally efficient, chromosome-focused strategy for targeted biomarker discovery in colorectal cancer

By restricting the analysis to chromosome 12, the pipeline enables a biologically relevant and resource-efficient approach to investigate clinically significant KRAS mutations, which are well-established predictive biomarkers of therapeutic response in colorectal cancer.

Overall, this project establishes a robust genomic biomarker identification framework that supports colorectal cancer research and provides a foundation for future expansion to additional cancer-associated genes, larger patient cohorts, or integration with epigenomic and transcriptomic data for comprehensive molecular characterization.

---

## Methodological Approach

The project leverages **RNA-based high-throughput technologies**, such as RNA sequencing (RNA-seq), to examine genome-wide expression changes between cancerous and normal tissues. Integrating transcriptomic data with known epigenetic regulatory mechanisms enables a deeper understanding of colorectal cancer biology.

This integrative framework supports:

- Early cancer detection
- Risk stratification
- Identification of therapeutic targets
- Development of personalized treatment strategies

---

## Significance

By uncovering key molecular drivers and epigenetic signatures, this project contributes to the discovery of **robust biomarkers** that may improve:

- Early diagnosis
- Prognostic accuracy
- Targeted therapy development

Ultimately, this work aims to advance precision medicine approaches and improve clinical outcomes for **colorectal cancer patients**.

---

## Repository Contents

- 📁 Epigenomic and transcriptomic analysis workflows  
- 📊 RNA-seq–based differential expression analysis  
- 🧬 Biomarker candidate identification  
- 📄 Documentation and reproducible pipelines  

---

## Getting Started

Please refer to the documentation provided in this repository to explore the analysis pipelines, datasets, and results.

---

